Bioengineered skin substitutes market seen reaching $4.66 billion by 2030

The bioengineered skin substitutes market is projected to grow from $2.48 billion in 2025 to $4.66 billion by 2030, driven by burn injuries, chronic wounds and wider use of regenerative medicine. North America held the largest regional share in 2025, while the report flags stronger demand for personalized wound care and tissue engineering.

Why it matters: - Demand is rising for advanced wound care products that can help treat burns, chronic wounds and reconstructive surgery patients. - The market's projected growth points to broader adoption of regenerative medicine and personalized wound care. - North America led the market in 2025, underscoring where current commercial activity is concentrated.

What happened: - The Bioengineered Skin Substitutes Market Report projected the market will grow from $2.48 billion in 2025 to $2.82 billion in 2026. - The report forecast the market will reach $4.66 billion by 2030. - The report estimated a 13.7% CAGR from 2025 to 2026 and a 13.4% CAGR from 2026 to 2030. - The report was published Nov. 5, 2026, from London.

The details: - Bioengineered skin substitutes are artificially created or laboratory-grown skin materials made from biological, synthetic or hybrid components. - These products are designed to mimic the structure and function of natural human skin. - The substitutes are used for severe skin injuries and conditions that require skin replacement or regeneration. - Common uses include burns, chronic wounds, ulcers and reconstructive surgeries. - The report linked market growth to more burn injuries, more chronic wounds, more reconstructive surgery, progress in tissue engineering, and wider product availability. - The report also pointed to stronger demand for bioactive skin regeneration products, advanced wound healing materials, personalized skin graft techniques, and products with better biocompatibility and healing efficacy. - A sample report is available here. - The full report is available here. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report said North America held the largest market share in 2025.

Between the lines: - The market outlook suggests healthcare systems are moving toward biologically advanced wound care rather than traditional dressings alone. - Burn growth is a major near-term driver because bioengineered skin can support healing, reduce infection risk and improve cosmetic and functional outcomes. - The report's emphasis on personalized treatment and clinical acceptance suggests adoption is widening from specialty use toward broader care pathways. - The report also said more investment in tissue engineering research is helping push the market forward.

What's next: - The report expects continued growth as aging populations increase chronic wound cases. - Further clinical use could expand as tissue engineering and regenerative medicine products improve. - Companies in the space are likely to focus on biocompatibility, healing performance and customized graft approaches. - The report's broader 2026 coverage adds market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, hotspot infographics and updated graphics and tables.

The bottom line: - Bioengineered skin substitutes are moving from a niche wound care option toward a larger regenerative medicine market, with burn injuries and chronic wound care driving the next wave of growth.